INS and type 1 diabetes mellitus: Clinical trials in adults with Type 1 diabetes have shown that insulin detemir is associated with comparable HbA1c, less variability in fasting plasma glucose, less nocturnal hypoglycaemia and less weight gain compared with intermediate-acting NPH 15–18.